James Hall, MD
Retina Specialist · Greenville, SCNPI 1538142179
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by US Retina LLC at 53.9% of the total. Reporting peaked in 2022 at $1,274 and has fallen 82.6% since, to $222 in 2025.
Across 100 payments — averaging $39.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- US Retina LLC$2K
- Regeneron Healthcare Solutions, Inc.$664
- Genentech USA, Inc.$335
- Novartis$165
- Bausch & Lomb Americas Inc.$140
- AbbVie$129
- plus $382 from 5 others
What the payments were for
- Food & beverage$1,81546%
- Ownership interest$2,12154%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| US Retina LLC | 6 | $2,121 |
| Regeneron Healthcare Solutions, Inc. | 27 | $664 |
| Genentech USA, Inc. | 22 | $335 |
| Novartis | 10 | $165 |
| Bausch & Lomb Americas Inc. | 7 | $140 |
| AbbVie(2 entities) | 7 | $129 |
| Alimera Sciences, Inc. | 7 | $128 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $94 |
| Apellis Pharmaceuticals, Inc. | 4 | $82 |
| Astellas Pharma US Inc | 3 | $60 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA$122
How this compares
$3,936 in reported general payments places this provider in the 65th percentile of 20 retina specialist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 133 | $5,835 |
| Bromfenac Sodium | 15 | $2,618 |
| Brimonidine Tartrate | 112 | $1,923 |
| Ketorolac Tromethamine | 88 | $1,271 |
| Latanoprost | 115 | $1,122 |
| Timolol Maleate | 65 | $557 |
| Dorzolamide Hcl | 32 | $523 |
| Acetazolamide | 12 | $457 |
| Ofloxacin | 26 | $354 |
| Diclofenac Sodium | 15 | $206 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $119 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Greenville
- Adam PflugrathGreenville$13K
- Hao TangCharleston$66K
- Carl BakerHilton Head Island$37K
- Jeffrey GrossColumbia$7K
- Arman FarrRock Hill$5K
- Stephen HypesWest Columbia$5K
- Robert PrinziLittle River$4K
- Jeffrey BliceCharleston$3K
- Charles TuckerRock Hill$2K
- Nasrollah SamiyRock Hill$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.